| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
40,460,000 |
| Market
Cap: |
166.70(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.1689 - $4.12 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile 180 Life Sciences is a clinical stage biotechnology company focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing research, and, where appropriate, combination therapy. Co.'s product development platforms that are focused on different diseases or medical conditions, and that target different factors, molecules or proteins, include: anti-tumor necrosis factor (TNF) platform, which is focusing on fibrosis and anti-TNF; synthetic cannabidiol analogs (SCA) platform, which is focusing on drugs which are synthetic cannabidiol or SCAs; and alpha 7 nicotinic acetylcholine receptor (a7nAChR) platform, which is focusing on a7nAChR.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
25,000 |
120,244 |
120,244 |
| Total Buy Value |
$0 |
$4,700 |
$108,459 |
$108,459 |
| Total People Bought |
0 |
1 |
5 |
5 |
| Total Buy Transactions |
0 |
1 |
8 |
8 |
| Total Shares Sold |
0 |
25,000 |
25,000 |
25,000 |
| Total Sell Value |
$0 |
$4,700 |
$4,700 |
$4,700 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
1 |
1 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mcgovern Jr. Donald A. |
Director |
– • – |
2022-05-19 |
4 |
A |
$1.36 |
$16,876 |
D/D |
12,409 |
50,587 |
|
- |
|
| Gold Lawrence |
Director |
– • – |
2022-05-19 |
4 |
A |
$1.36 |
$14,375 |
D/D |
10,570 |
22,028 |
|
- |
|
| Ray Russell T |
Director |
– • – |
2022-01-14 |
4 |
A |
$3.04 |
$14,373 |
D/D |
4,728 |
4,728 |
|
- |
|
| Marrone Pamela G |
Director |
– • – |
2022-01-14 |
4 |
A |
$3.04 |
$7,500 |
D/D |
2,467 |
3,467 |
|
- |
|
| Mcgovern Jr. Donald A. |
Director |
– • – |
2022-01-14 |
4 |
A |
$3.04 |
$16,872 |
D/D |
5,550 |
38,178 |
|
- |
|
| Gold Lawrence |
Director |
– • – |
2022-01-14 |
4 |
A |
$3.04 |
$14,373 |
D/D |
4,728 |
11,458 |
|
- |
|
| Vu Quan Anh |
COO / Chief Business Officer |
• – – |
2021-12-16 |
4 |
B |
$3.98 |
$31,840 |
D/D |
8,000 |
20,500 |
2.74 |
-56% |
|
| Pamir Ozan |
Interim CFO |
• – – |
2021-12-10 |
4 |
B |
$3.87 |
$14,706 |
D/D |
3,800 |
76,408 |
2.74 |
-58% |
|
| Vu Quan Anh |
COO / Chief Business Officer |
• – – |
2021-12-10 |
4 |
B |
$3.90 |
$17,550 |
D/D |
4,500 |
12,500 |
2.74 |
-58% |
|
| Marrone Pamela G |
Director |
– • – |
2021-12-10 |
4 |
B |
$4.10 |
$4,100 |
D/D |
1,000 |
1,000 |
2.31 |
-58% |
|
| Feldmann Marc |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.07 |
$203,500 |
D/D |
50,000 |
2,809,930 |
2.39 |
-57% |
|
| Deluca Teresa |
Director |
– • – |
2021-12-09 |
4 |
B |
$3.95 |
$29,800 |
I/I |
7,500 |
2,500 |
2.1 |
-57% |
|
| Deluca Teresa |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
5,000 |
2.39 |
-57% |
|
| Woody James N. |
Chief Executive Officer |
• • – |
2021-12-09 |
4 |
B |
$4.27 |
$53,375 |
D/D |
12,500 |
37,752 |
2.81 |
-57% |
|
| Steinman Lawrence |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.27 |
$21,350 |
D/D |
5,000 |
602,574 |
2.39 |
-57% |
|
| Mcgovern Jr. Donald A. |
Director |
– • – |
2021-12-09 |
4 |
B |
$4.13 |
$103,250 |
D/D |
25,000 |
32,628 |
2.39 |
-57% |
|
| Feldmann Marc |
Director |
– • – |
2021-12-08 |
4 |
A |
$3.95 |
$21,867 |
D/D |
5,536 |
2,759,930 |
|
- |
|
| Vu Quan Anh |
COO / Chief Business OfficerOf |
• – – |
2021-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,000 |
|
-47% |
|
| Feldmann Marc |
Director |
– • – |
2021-09-30 |
4 |
A |
$6.00 |
$819,816 |
D/D |
136,636 |
2,754,394 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2021-09-30 |
4 |
A |
$6.00 |
$31,296 |
D/D |
5,216 |
597,574 |
|
- |
|
| Gold Lawrence |
Director |
– • – |
2021-08-04 |
4 |
A |
$7.56 |
$34,995 |
D/D |
4,629 |
6,730 |
|
- |
|
| Mcgovern Jr. Donald A. |
Director |
– • – |
2021-08-04 |
4 |
A |
$7.56 |
$38,745 |
D/D |
5,125 |
7,628 |
|
- |
|
| Feldmann Marc |
Director |
– • – |
2021-04-07 |
4 |
A |
$6.14 |
$128,387 |
D/D |
20,910 |
2,617,758 |
|
- |
|
| Rothbard Jonathan B. |
Chief Scientific Officer |
• – – |
2021-04-07 |
4 |
A |
$6.14 |
$149,245 |
D/D |
24,307 |
560,449 |
|
- |
|
| Steinman Lawrence |
Director |
– • – |
2021-04-07 |
4 |
A |
$6.14 |
$138,672 |
D/D |
22,585 |
592,358 |
|
- |
|
95 Records found
|
|
Page 2 of 4 |
|
|
